Table 1 Summary of the cases of Behçet’s disease uveitis associated with a pre-papillary vitreous infiltrate reported in literature
From: Behçet’s disease presenting as neuroretinitis with pre-papillary vitreous infiltrate: a case report
Reference | Age (years) | Sex | Behçet’s disease symptoms | Background treatment | Treatment of the current episode | Time to resolution of the pre-papillary vitreous infiltrate |
|---|---|---|---|---|---|---|
Nakamura et al. [4] | 34 | Female | Neuro Behçet’s disease, mucocutaneous lesions and uveitis. | -Prednisolone 25 mg/ day. -Colchicine 1 mg/day. | -Subtenon injection of 0.3 ml dexamethasone. -Augmentation of colchicine dosage to 1.5 mg/day. | 11 days. |
Schwartz et al. [5] | 23 | Male | Neuro Behçet’s disease and uveitis. | -Prednisone 12.5 mg/day. -Azathioprine 150 mg/day. | -Augmentation of prednisone dosage to 60 mg/day. | 7 days. |
Grotting et al. [6] | 46 | Female | Mucocutaneous lesions and uveitis. | - (Infliximab infusions stopped 1 year before flare-up). | -IV Methylprednisolone 500 mg/day then oral prednisone 60 mg/day. | 2 months. |
36 | Male | Mucocutaneous lesions and uveitis. | -Prednisone 60 mg/day. | -IV Methylprednisolone 1 g/day. -Sub-tenon injection of Triamcinolone. | 4 months. | |
26 | Male | Pericarditis and uveitis. | -Azathioprine 200 mg/day. | -Prednisone 60 mg/day. -Adalimumab. | 3 weeks. | |
Tugal-Tutkun et al. [7] | 37 | Female | Uveitis (No additional details). | Not mentioned. | Not mentioned. | 6 months. |
35 | Female | Uveitis (No additional details). | Not mentioned. | Not mentioned. | 3 weeks. | |
Ksiaa et al. [8] | 37 | Male | Mucocutaneous lesions and uveitis. | – | -Prednisone 1 mg/kg/day. -Azathioprine 3 mg/kg/day. | 1 month. |
Our case | 43 | Male | Mucocutaneous lesions and uveitis. | – | -IV Methylprednisolone 1 g/ per day for 3 days then oral prednisone 1 mg/kg/day. -Azathioprine 150 mg/day. -Ciclosporin 200 mg/day | 15 days. |